This compound is a macrocyclic peptide-like substance used as an antifungal active pharmaceutical ingredient. Its structure features multiple hydroxyl and amide groups, contributing to its high polarity and low lipophilicity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Echinocandin B, 1-[(4R,5R)-4,5-dihydroxy-L-ornithine]-?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Itraconazole
pharmaceutical raw material
Liranaftate
pharmaceutical raw material
Terbinafine
pharmaceutical raw material
Isavuconazonium sulfate
pharmaceutical raw material
San 201-456
pharmaceutical raw material
Levocabastine
pharmaceutical raw material
Octreotide acetate
pharmaceutical raw material
Sertraline hydrochloride
pharmaceutical raw material
18-amino-6-[1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis(1-hydroxyethyl)-26-methyl-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosane-2,5,8,14,17,23-hexone
BLKJKIJFNJAQIZ-UHFFFAOYSA-N
CC1CN2C(C1O)C(=O)NC(C(CC(C(=O)NC(C(=O)N3CC(CC3C(=O)NC(C(=O)NC(C2=O)C(C)O)C(C(C4=CC=C(C=C4)O)O)O)O)C(C)O)N)O)O
Sourcing Echinocandin B, 1-[(4R,5R)-4,5-dihydroxy-L-ornithine]-?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.